TRIGLYCERIDE LOWERING EFFECT OF MAXEPA FISH LIPID CONCENTRATE - A MULTICENTER PLACEBO CONTROLLED DOUBLE-BLIND STUDY

被引:20
|
作者
MILLER, JP
HEATH, ID
CHORARIA, SK
SHEPHARD, NW
GAJENDRAGADKAR, RV
HARCUS, AW
BATSON, GA
SMITH, DW
SAYNOR, R
机构
[1] MEDICOS LTD, MEDICOS HOUSE, 79 BEVERLEY RD, HULL HU3 1XR, N HUMBERSIDE, ENGLAND
[2] UNIV HOSP S MANCHESTER, MANCHESTER M20 8LR, LANCS, ENGLAND
[3] HALIFAX GEN HOSP, HALIFAX, NS, CANADA
[4] WALSGRAVE HOSP, COVENTRY CV2 2DY, W MIDLANDS, ENGLAND
[5] W MIDDLESEX HOSP, ISLEWORTH, MIDDX, ENGLAND
[6] KING KHALID HOSP, NAJRAN, EGYPT
[7] SCUNTHORPE GEN HOSP, SCUNTHORPE, ENGLAND
[8] NO GEN HOSP, SHEFFIELD S5 7AU, S YORKSHIRE, ENGLAND
[9] HUBY, YORK, ENGLAND
关键词
D O I
10.1016/0009-8981(88)90233-1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:251 / 260
页数:10
相关论文
共 50 条
  • [1] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FISH OIL CONCENTRATE (MAXEPA) IN STROKE PATIENTS
    GREEN, D
    BARRERES, L
    BORENSZTAJN, J
    KAPLAN, P
    REDDY, MN
    ROVNER, R
    SIMON, H
    STROKE, 1985, 16 (04) : 706 - 709
  • [2] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MAXEPA IN STROKE PATIENTS
    GREEN, D
    BARRERAS, LR
    BORENSZTAJN, J
    REDDY, N
    ROVNER, R
    SIMON, H
    CLINICAL RESEARCH, 1984, 32 (02): : A309 - A309
  • [3] The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
    Santos, Jose R.
    Saumoy, Maria
    Curran, Adrian
    Bravo, Isabel
    Llibre, Josep M.
    Navarro, Jordi
    Estany, Carla
    Podzamczer, Daniel
    Ribera, Esteban
    Negredo, Eugenia
    Clotet, Bonaventura
    Paredes, Roger
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (03) : 403 - 408
  • [4] EFFECT OF MAXEPA IN PATIENTS WITH SLE - A DOUBLE-BLIND, CROSSOVER STUDY
    WESTBERG, G
    TARKOWSKI, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1990, 19 (02) : 137 - 143
  • [5] CHOLESTEROL LOWERING EFFECT OF METFORMIN IN COMBINED HYPERLIPIDEMIA - PLACEBO CONTROLLED DOUBLE-BLIND TRIAL
    PENTIKAINEN, PJ
    VOUTILAINEN, E
    ARO, A
    UUSITUPA, M
    PENTTILA, I
    VAPAATALO, H
    ANNALS OF MEDICINE, 1990, 22 (05) : 307 - 312
  • [6] Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study
    Lott, M
    Greist, JH
    Jefferson, JW
    Kobak, KA
    Katzelnick, DJ
    Katz, RJ
    Schaettle, SC
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (04) : 255 - 260
  • [7] Cabergoline in restless legs syndrome - a double-blind, placebo controlled multicenter study
    Leissner, L. C.
    Grote, L. B.
    Ulfbcrg, J. G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 302 - 302
  • [8] SULFASALAZINE IN SPONDYLARTHROPATHY - A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    DOUGADOS, M
    VANDERLINDEN, S
    LEIRISALOREPO, M
    HUITFELDT, B
    BERTOUCH, J
    BROOKS, P
    DIJKMANS, B
    EDMONDS, J
    MAJOR, G
    KVIEN, T
    OLIVIERI, I
    VEYS, E
    ZEIDLER, H
    AMOR, B
    CALIN, A
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S92 - S92
  • [9] The effect of urapidil on neurogenic bladder: A placebo controlled double-blind study
    Yasuda, K
    Yamanishi, T
    Kawabe, K
    Ohshima, H
    Morita, T
    JOURNAL OF UROLOGY, 1996, 156 (03): : 1125 - 1130
  • [10] DOUBLE-BLIND, CONTROLLED, MULTICENTER STUDY OF INDOBUFEN VERSUS PLACEBO IN PATIENTS WITH INTERMITTENT CLAUDICATION
    TONNESEN, KH
    ALBUQUERQUE, P
    BAITSCH, G
    ALONSO, AG
    IBANEZ, F
    KESTER, RC
    LEVESON, S
    POREDOS, P
    INTERNATIONAL ANGIOLOGY, 1993, 12 (04) : 371 - 377